It’s been a difficult year for the drug industry —as far as reputations go.
Pharmaceutical giants and small biotechnology companies have been scrutinized for the way they price new, life-saving drugs, how they jack up prices on old drugs, and even for striking deals aimed at avoiding US taxes.
Now, Pfizer is making an effort to turn things around with a new ad campaign highlighting the science behind its products.
